120 related articles for article (PubMed ID: 10457543)
1. Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra.
Landolt HP; Meier V; Burgess HJ; Finelli LA; Cattelin F; Achermann P; Borbély AA
Neuropsychopharmacology; 1999 Sep; 21(3):455-66. PubMed ID: 10457543
[TBL] [Abstract][Full Text] [Related]
2. The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade.
Seifritz E; Moore P; Trachsel L; Bhatti T; Stahl SM; Gillin JC
Neurosci Lett; 1996 May; 209(1):41-4. PubMed ID: 8734905
[TBL] [Abstract][Full Text] [Related]
3. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.
Kantor S; Jakus R; Bodizs R; Halasz P; Bagdy G
Brain Res; 2002 Jul; 943(1):105-11. PubMed ID: 12088844
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
Rinaldi-Carmona M; Congy C; Santucci V; Simiand J; Gautret B; Neliat G; Labeeuw B; Le Fur G; Soubrie P; Breliere JC
J Pharmacol Exp Ther; 1992 Aug; 262(2):759-68. PubMed ID: 1501121
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: effect of midazolam and zopiclone.
Aeschbach D; Dijk DJ; Trachsel L; Brunner DP; Borbély AA
Neuropsychopharmacology; 1994 Dec; 11(4):237-44. PubMed ID: 7857498
[TBL] [Abstract][Full Text] [Related]
6. Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505.
Kantor S; Jakus R; Balogh B; Benko A; Bagdy G
Br J Pharmacol; 2004 Aug; 142(8):1332-42. PubMed ID: 15265808
[TBL] [Abstract][Full Text] [Related]
7. Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram.
Neckelmann D; Bjørkum AA; Bjorvatn B; Ursin R
Behav Brain Res; 1996 Feb; 75(1-2):159-68. PubMed ID: 8800653
[TBL] [Abstract][Full Text] [Related]
8. Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain.
Rinaldi-Carmona M; Congy C; Simiand J; Oury-Donat F; Soubrie P; Breliere JC; Le Fur G
Mol Pharmacol; 1993 Jan; 43(1):84-9. PubMed ID: 8423772
[TBL] [Abstract][Full Text] [Related]
9. Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra.
Kantor S; Jakus R; Molnar E; Gyongyosi N; Toth A; Detari L; Bagdy G
J Pharmacol Exp Ther; 2005 Nov; 315(2):921-30. PubMed ID: 16085759
[TBL] [Abstract][Full Text] [Related]
10. The effects of ethanol on human sleep EEG power spectra differ from those of benzodiazepine receptor agonists.
Dijk DJ; Brunner DP; Aeschbach D; Tobler I; Borbély AA
Neuropsychopharmacology; 1992 Nov; 7(3):225-32. PubMed ID: 1326982
[TBL] [Abstract][Full Text] [Related]
11. Further evidence that various 5-HT receptor subtypes modulate central respiratory activity: in vitro studies with SR 46349B.
Monteau R; Di Pasquale E; Hilaire G
Eur J Pharmacol; 1994 Jun; 259(1):71-4. PubMed ID: 7957597
[TBL] [Abstract][Full Text] [Related]
12. Caffeine reduces low-frequency delta activity in the human sleep EEG.
Landolt HP; Dijk DJ; Gaus SE; Borbély AA
Neuropsychopharmacology; 1995 May; 12(3):229-38. PubMed ID: 7612156
[TBL] [Abstract][Full Text] [Related]
13. The visual scoring of sleep and arousal in infants and children.
Grigg-Damberger M; Gozal D; Marcus CL; Quan SF; Rosen CL; Chervin RD; Wise M; Picchietti DL; Sheldon SH; Iber C
J Clin Sleep Med; 2007 Mar; 3(2):201-40. PubMed ID: 17557427
[TBL] [Abstract][Full Text] [Related]
14. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
van Laar M; Volkerts E; Verbaten M
Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
[TBL] [Abstract][Full Text] [Related]
15. Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers.
Viola AU; Brandenberger G; Toussaint M; Bouhours P; Paul Macher J; Luthringer R
Clin Neurophysiol; 2002 Mar; 113(3):429-34. PubMed ID: 11897543
[TBL] [Abstract][Full Text] [Related]
16. The 5-HT2 antagonist ritanserin decreases sleep in cats.
Sommerfelt L; Ursin R
Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of EEG slow-wave activity and core body temperature in human sleep after exposure to bright light.
Cajochen C; Dijk DJ; Borbély AA
Sleep; 1992 Aug; 15(4):337-43. PubMed ID: 1519009
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of EEG spindle frequency activity during extended sleep in humans: relationship to slow-wave activity and time of day.
Aeschbach D; Dijk DJ; Borbély AA
Brain Res; 1997 Feb; 748(1-2):131-6. PubMed ID: 9067453
[TBL] [Abstract][Full Text] [Related]
19. EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia.
Lundahl J; Deacon S; Maurice D; Staner L
J Psychopharmacol; 2012 Aug; 26(8):1081-7. PubMed ID: 22057018
[TBL] [Abstract][Full Text] [Related]
20. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra.
Dijk DJ; Beersma DG; Daan S; van den Hoofdakker RH
Eur J Pharmacol; 1989 Nov; 171(2-3):207-18. PubMed ID: 2576000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
